Harvard Bioscience Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for HBIO, updated each market day.
HBIO AI Sentiment
AI sees no strong directional signal for Harvard Bioscience Inc stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Harvard Bioscience Inc
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Sector
Exchange
Market Cap
$24,014,580
Cap Tier
Employees
339
Headquarters
HOLLISTON, MA
Listed Since
Dec. 7, 2000
HBIO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
HBIO Volatility
Harvard Bioscience Inc has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
